Doctor profile · Federal record

Dr. Karla Giese, CFNP

Endocrinology, Diabetes & Metabolism Physician (CMS: Nurse Practitioner) · Endocrinology, Diabetes & Metabolism Physician · Nurse Practitioner · Family Nurse Practitioner · Traverse City, MI

  • NPI 1780676262
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 13 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1221 Sixth St Ste 208
Traverse City, MI 496842360
(231) 935-2045
fax (231) 935-3420
Additional location
6701 Jefferson St Ne
Albuquerque, NM 871094318
(505) 727-6200
fax (505) 727-9590

Credentials & registration

NPPES · NUCC
NPI registered
August 2005 — 21 yrs on file
Profile last updated
June 27, 2022
Year of graduation
2013 — 13 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (3)
Michigan #4704393100 · New Mexico #CNP01405 · New Mexico #R61595
Medicaid
NM #53483561

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1780676262. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
180
Distinct HCPCS
3
Medicare allowed
$13,173
HCPCS Description Services Patients Avg allowed
99215 Established patient office or other outpatient visit, 40-54 minutes 79 47 $115
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 76 41 $28
99214 Established patient office or other outpatient visit, 30-39 minutes 25 18 $77

In context: peer comparison

Among 3 peers in Traverse City Endocrinology, Diabetes & Metabolism Physician, average services per provider: 89. This provider delivers 2.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,985
Transactions
40
Manufacturers
8
Payer (manufacturer) Industry Txns Amount
Medtronic, INC. 15 $2,021.87
Sanofi-Aventis U.S. LLC 4 $277.90
Lilly USA, LLC 5 $210.75
Dexcom, INC. 5 $202.78
Novo Nordisk INC 7 $141.84
Acadia Pharmaceuticals INC 1 $79.01
Insulet Corporation 2 $30.15
Tandem Diabetes Care, INC. 1 $20.42

By nature of payment

Travel and Lodging
$1,518
Food and Beverage
$1,467

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
602
Patients
171
Total drug cost
$605,187
Drug Type Claims Patients Total cost
Trulicity (Dulaglutide) Brand 108 30 $160,076
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 69 28 $65,666
Jardiance (Empagliflozin) Brand 66 22 $72,476
Ozempic (Semaglutide) Brand 44 13 $60,893
Tresiba Flextouch U-100 (Insulin Degludec) Brand 33 0 $34,508
Metformin Hcl Generic 32 15 $504
Losartan Potassium Generic 31 0 $543
Metformin Hcl ER (Metformin Hcl) Brand 31 16 $578
Tresiba Flextouch U-200 (Insulin Degludec) Brand 31 12 $72,066
Farxiga (Dapagliflozin Propanediol) Brand 29 12 $41,118

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Karla Giese's medical specialty?
Dr. Karla Giese practices Endocrinology, Diabetes & Metabolism Physician in Traverse City, MI.
Where does Dr. Karla Giese practice?
Dr. Karla Giese practices at 1221 Sixth St Ste 208, Traverse City, MI 496842360. Office phone: 2319352045.
What is Dr. Karla Giese's NPI?
Dr. Karla Giese's National Provider Identifier (NPI) is 1780676262, issued by NPPES.
Does Dr. Karla Giese accept Medicare assignment?
Yes. Dr. Karla Giese accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Karla Giese commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.